De novo design of a peptide modulator to reverse sodium channel dysfunction linked to cardiac arrhythmias and epilepsy is a research paper published in Cell (2025). On theSindex it has a DataRank of 0.442. It has been cited 18 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.442
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NHLBI NIH HHS
Grant: P01 HL141084
NCRR NIH HHS
Grant: S10 RR027050
NINDS NIH HHS
Grant: R01 NS126392
NHLBI NIH HHS
Grant: R01 HL163576
NHLBI NIH HHS
Grant: K08 HL151969
NHLBI NIH HHS
Grant: R01 HL142282
NIH HHS
Grant: DP5 OD026389
NHLBI NIH HHS
Grant: T32 HL120826
NHLBI NIH HHS
Grant: R01 HL140934
American Heart Association Inc
National Institutes of Health Office of the Director
National Institute of Neurological Disorders and Stroke
National Heart Lung and Blood Institute Division of Intramural Research
FWCI
14.17
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals